The Earnings Trends report indicates that as of Jan. 29, 12.3% of the companies in the Medical sector — representing 30.8% of the sector’s market capitalization — reported quarterly earnings.

Stay updated on biotech earnings announcements. Monitor upcoming PDUFA dates and FDA approval dates. Highlights top stocks, volume, and news movers. Reference past PDUFA decisions. Keep up with biotech and pharma conferences. Upcoming and Past IPOs. Track biotech catalysts ahead of the competition.

Our Biotech Earnings Calendar displays earnings and earnings estimates for biotech companies we cover. We source earnings and revenue estimates from several different sources, including Benzinga and Estimize.

2025年1月30日 · On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus away from enormous takeovers to single-digit billion buy outs. JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year.

1 天前 · It was a busy week for the biotech sector as the fourth-quarter earnings season kicked in. While Regeneron (REGN Quick Quote REGN - Free Report) gained following the announcement, Amgen (AMGN ...

2024年2月21日 · Bellwether J&J reported strong fourth-quarter results, wherein its earnings and sales beat their respective estimates. Swiss pharma giant Novartis’ sales and earnings lagged their respective...

3 天之前 · The fourth-quarter 2024 reporting cycle of the Medical sector is in full swing. The sector primarily comprises pharma/biotech and medical device companies. See the Zacks Earnings Calendar to stay ahead of market-making news. The earnings season for the medical sector kicked off late last month when pharma giant J&J reported fourth-quarter earnings.

22 小时之前 · This week in biotech earnings so far. GSK announced a share buyback Wednesday morning and raised its long-term growth forecast. ... Stocks of vaccine makers dropped yesterday on the news, with ...

2024年2月5日 · Several large drug and biotech stocks have already announced fourth-quarter results so far. A few industry players like Regeneron, AbbVie, Roche and Bristol-Myers beat on both earnings and...

2024年11月11日 · Let's look at five biotech and drug companies, AZN, NVAX, AXSM, TBPH and PRTA, slated to release their third-quarter 2024 results this week.